Holding Sidani Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Holding Sidani Pharma
Largest movements
- Deferred charges and accrued income -€24,504
down €24,504 (-100%), from €24,504 to €0
- Trade debts -€86,799
down €86,799 (-98.6%), from €88,018 to €1,219
- Debts after one year -€72,501
down €72,501 (-4.4%), from €1.7m to €1.6m
of which Financial debts: -€72,501
- Reserves +€63,204
new in 2025: €63,204
- Other debts +€54,603
up €54,603 (+321%), from €17,000 to €71,603
- Gross operating margin +€90,086
new in 2025: €90,086
- Financial charges +€78,314
new in 2025: €78,314
- Financial income +€70,000
new in 2025: €70,000
- Depreciation +€17,760
new in 2025: €17,760
From the 2024 result to the 2025 result
The net result is not in both sets of accounts; without it the difference cannot be explained line by line.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,035,018 | €2,008,069 | -€26,949 | -1.3% |
| Formation expenses | 20 | €1,172 | €781 | -€391 | -33.3% |
| Fixed assets | 21/28 | €1,916,847 | €1,899,477 | -€17,369 | -0.9% |
| Tangible fixed assets | 22/27 | €666,847 | €649,477 | -€17,369 | -2.6% |
| Land and buildings | 22 | €666,847 | €649,477 | -€17,369 | -2.6% |
| Financial fixed assets | 28 | €1,250,000 | €1,250,000 | = | 0.0% |
| Current assets | 29/58 | €117,000 | €107,811 | -€9,189 | -7.9% |
| Amounts receivable within one year | 40/41 | €92,108 | €94,687 | +€2,578 | +2.8% |
| Trade receivables | 40 | €92,108 | €94,687 | +€2,578 | +2.8% |
| Cash at bank and in hand | 54/58 | €387 | €13,124 | +€12,737 | +3,287% |
| Deferred charges and accrued income | 490/1 | €24,504 | €0 | -€24,504 | -100% |
| Total equity and liabilities | 10/49 | €2,035,018 | €2,008,069 | -€26,949 | -1.3% |
| Equity | 10/15 | €200,000 | €263,204 | +€63,204 | +31.6% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | - | €63,204 | +€63,204 | |
| Distributable reserves | 133 | - | €63,204 | +€63,204 | |
| Amounts payable | 17/49 | €1,835,018 | €1,744,865 | -€90,153 | -4.9% |
| Amounts payable after more than one year | 17 | €1,664,953 | €1,592,452 | -€72,501 | -4.4% |
| Financial debts | 170/4 | €1,464,953 | €1,392,452 | -€72,501 | -4.9% |
| Other amounts payable | 178/9 | €200,000 | €200,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €170,066 | €152,409 | -€17,657 | -10.4% |
| Current portion of amounts payable after more than one year | 42 | €65,047 | €72,501 | +€7,454 | +11.5% |
| Trade debts | 44 | €88,018 | €1,219 | -€86,799 | -98.6% |
| Suppliers | 440/4 | €88,018 | €1,219 | -€86,799 | -98.6% |
| Taxes, remuneration and social security | 45 | - | €7,086 | +€7,086 | |
| Taxes | 450/3 | - | €7,086 | +€7,086 | |
| Other amounts payable | 47/48 | €17,000 | €71,603 | +€54,603 | +321% |
| Accrued charges and deferred income | 492/3 | - | €4 | +€4 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €17,760 | +€17,760 | |
| Other operating charges | 640/8 | - | €808 | +€808 | |
| Gross operating margin | 9900 | - | €90,086 | +€90,086 | |
| Operating profit (loss) | 9901 | - | €71,518 | +€71,518 | |
| Financial income | 75/76B | - | €70,000 | +€70,000 | |
| Recurring financial income | 75 | - | €70,000 | +€70,000 | |
| Financial charges | 65/66B | - | €78,314 | +€78,314 | |
| Recurring financial charges | 65 | - | €78,314 | +€78,314 | |
| Profit (loss) for the period before taxes | 9903 | - | €63,204 | +€63,204 | |
| Profit (loss) for the period | 9904 | - | €63,204 | +€63,204 | |
| Profit (loss) for the period to be appropriated | 9905 | - | €63,204 | +€63,204 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.